Medicare Enrolled
Dr. Chantal Devillena, MD
Dermatology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Devillena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Devillena?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Devillena
Dr. Chantal Devillena is a dermatology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Devillena performed 28,170 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Devillena received a total of $7,897 from 41 pharmaceutical and/or device companies across 438 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Devillena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in TX
$7,897 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗28,170
Medicare services
Top 1% in TX for dermatology
Not available
Unique patients (not deduplicated)
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 19,000 | $1 | $5 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
3,213 | $5 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,855 | $84 | $155 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
1,016 | $35 | $95 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
671 | $60 | $145 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
532 | $81 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $62 | $110 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
233 | $37 | $80 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
208 | $116 | $285 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
149 | $1 | $5 |
| Destruction of skin growth, 15 or more growths | 144 | $87 | $160 |
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
125 | $88 | $150 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
106 | $103 | $170 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
104 | $221 | $365 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $102 | $200 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
87 | $94 | $295 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
39 | $45 | $90 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
30 | $45 | $145 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
26 | $89 | $185 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
24 | $66 | $205 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
22 | $68 | $140 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
22 | $98 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $128 | $250 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
19 | $88 | $150 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
17 | $278 | $425 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
15 | $11 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $82 | $140 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
14 | $112 | $215 |
| Lip biopsy A procedure to remove a small sample of tissue from the lip for laboratory examination. |
12 | $62 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
4.2% medium
95.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,897
Total received (2018-2024)
Avg $1,128/year across 7 years
Top 34% in TX for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
438
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,390
2023
$1,747
2022
$1,521
2021
$587
2020
$382
2019
$650
2018
$620
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$614
ABBVIE INC.
$593
Lilly USA, LLC
$170
Amgen Inc.
$150
Regeneron Healthcare Solutions, Inc.
$138
Arcutis Biotherapeutics, Inc.
$137
Janssen Biotech, Inc.
$90
UCB, Inc.
$70
Novartis Pharmaceuticals Corporation
$64
Dermavant Sciences, Inc.
$61
GENZYME CORPORATION
$55
PFIZER INC.
$50
Incyte Corporation
$47
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
REVANCE THERAPEUTICS, INC.
$27
Krystal Biotech Inc
$27
Kerecis Limited
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Biofrontera Inc.
$18
Top 3 companies account for 57.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,118
E.R. Squibb & Sons, L.L.C.
$837
AbbVie Inc.
$627
Janssen Biotech, Inc.
$587
Lilly USA, LLC
$579
Regeneron Healthcare Solutions, Inc.
$443
AbbVie, Inc.
$439
GENZYME CORPORATION
$411
Amgen Inc.
$409
Novartis Pharmaceuticals Corporation
$272
Arcutis Biotherapeutics, Inc.
$268
LEO Pharma Inc.
$205
PFIZER INC.
$205
Sun Pharmaceutical Industries Inc.
$155
UCB, Inc.
$145
Incyte Corporation
$140
Almirall LLC
$103
VYNE Pharmaceuticals Inc.
$99
Biofrontera Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Dermavant Sciences, Inc.
$77
Mayne Pharma Inc.
$65
Helsinn Therapeutics (U.S.), Inc.
$61
Ortho Dermatologics, a division of Bausch Health US, LLC
$47
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
EPI Health, LLC
$45
Journey Medical Corporation
$42
Celgene Corporation
$28
REVANCE THERAPEUTICS, INC.
$27
Krystal Biotech Inc
$27
Kerecis Limited
$26
Mylan Pharmaceuticals Inc.
$24
Medimetriks Pharmaceuticals, Inc.
$23
Galderma Laboratories, L.P.
$22
MAYNE PHARMA INC.
$22
Nabriva Therapeutics, plc
$20
Kyowa Kirin, Inc.
$19
Blueprint Medicines Corporation
$18
SANOFI-AVENTIS U.S. LLC
$17
Taro Pharmaceuticals USA, Inc.
$15
Genentech USA, Inc.
$11
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · AMELUZ · AMZEEQ · Absorica LD · BLU-U · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Erivedge · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · JUBLIA · Kerecis Omega3 SurgiClose · LIBTAYO · OLUMIANT · OPZELURA · ORACEA · Odomzo · Olux · Otezla · POTELIGEO · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · USP) 0.1% · VALCHLOR · VTAMA · VYJUVEK · Veltin · Winlevi · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
115
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Devillena is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Devillena experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Devillena performed 19,000 photodynamic therapy gel for precancerous skin services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Devillena receive payments from pharmaceutical companies?
Yes. Dr. Devillena received a total of $7,897 from 41 companies across 438 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Devillena's costs compare to other dermatologists in San Antonio?
Dr. Devillena's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Devillena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in San Antonio
Browse dermatologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology